| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/27/2013 | CN102382825B Human miR-1826 antisense nucleic acid and application thereof |
| 02/27/2013 | CN102373206B PPP2R5C-siRNA799 for targeted inhabitation of PPP2R5C gene expression and tumor T cell multiplication and application thereof |
| 02/27/2013 | CN102260376B Novel cationic polymer used for non-virus type gene carrier, its preparation method and its purpose |
| 02/27/2013 | CN102229932B Nucleic acid aptamer capable of identifying HCV E1E2 (hepatitis C virus E1E2), nucleic acid aptamer derivatives and screening method and application thereof |
| 02/27/2013 | CN102160894B Benzamide analog mediated brain-targeting delivery system |
| 02/26/2013 | US8383807 MicroRNA and methods for inhibiting same |
| 02/26/2013 | US8383794 Conformation-selective nucleic acid inhibitors of AMPA glutamate receptors |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383789 Vasopressin-binding L-nucleic acid |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |
| 02/26/2013 | US8383601 Tissue specific gene therapy treatment |
| 02/26/2013 | US8383599 Methods and compositions for RNA interference |
| 02/26/2013 | US8383598 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 02/26/2013 | US8383405 Methods of using ideotypically modulated pharmacoeffectors for selective cell treatment |
| 02/26/2013 | US8383398 Expression vector |
| 02/26/2013 | US8383394 System and method for electroporating a sample |
| 02/26/2013 | US8383145 Film-form preparation |
| 02/26/2013 | US8383132 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use |
| 02/26/2013 | US8383091 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2632013C Adenovirus 36 e4 orf 1 gene and protein and their uses |
| 02/26/2013 | CA2509979C Alphavirus particles and methods for preparation |
| 02/26/2013 | CA2509973C Multi-antigenic alphavirus replicon particles and methods |
| 02/26/2013 | CA2493406C Gm-negative ehv-mutants without heterologous elements |
| 02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
| 02/21/2013 | WO2013026021A2 Trka as a target for inhibiting app cleavage and/or progression of alzheimer's disease |
| 02/21/2013 | WO2013025930A1 Aptamer modulators of estrogen receptors |
| 02/21/2013 | WO2013025834A2 Compositions and methods related to antibodies to staphylococcal protein a |
| 02/21/2013 | WO2013025474A2 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 02/21/2013 | WO2013025461A1 Compositions and methods for inducing apoptosis |
| 02/21/2013 | WO2013025418A1 Delivery system for specifically targeting cancer cells and method of use thereof |
| 02/21/2013 | WO2013025064A2 Anti-cancer composition comprising wnt decoy receptors |
| 02/21/2013 | WO2013024433A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 02/21/2013 | WO2013023361A1 Uses of human zfx gene and related drugs thereof |
| 02/21/2013 | WO2012174549A9 Blockade of eosinophil production by toll-like receptors |
| 02/21/2013 | WO2012158624A3 Inhibitors of mitochondrial fission and methods of use thereof |
| 02/21/2013 | WO2012154271A3 Method and cells for identifying rig-i pathway regulators |
| 02/21/2013 | WO2012112792A3 Multicomponent compositions and their uses |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045234 Neutralizing factors as vaccine adjuvants |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045180 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2013 | CA2845541A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 02/21/2013 | CA2845259A1 Compositions and methods related to antibodies to staphylococcal protein a |
| 02/20/2013 | EP2559759A1 Custom-made meganuclease and use thereof |
| 02/20/2013 | EP2559443A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 02/20/2013 | EP2559441A2 Protein complex for intracellular delivery and uses thereof |
| 02/20/2013 | EP2558128A2 Methods and compositions for treating hiv |
| 02/20/2013 | CN102936288A Erythropoietin mimetic peptide fusion protein and mutant |
| 02/20/2013 | CN102935240A Rabbit hemorrhagic disease virus (RHDV) 'suicide' deoxyribonucleic acid (DNA) vaccine and construction method thereof |
| 02/20/2013 | CN102935239A Preparation for preventing or treating lung cancers and preparation method and application thereof |
| 02/20/2013 | CN102935238A Application of yeast M-dsRNA as TLR3 agonist, and yeast M-dsRNA preparation method |
| 02/20/2013 | CN102233137B Recombinant plasmid DNA vaccine composition for treating Hepatitis B |
| 02/20/2013 | CN101903046B Constructs containing multiple expression cassettes for cancer therapy |
| 02/20/2013 | CN101701219B cDNA for encoding rabbit hepatocyte growth factor and expression vector and application thereof |
| 02/19/2013 | US8378088 Compositions comprising MIR34 therapeutic agents for treating cancer |
| 02/19/2013 | US8377900 Coumermycin/novobicin-regulated gene expression system |
| 02/19/2013 | US8377898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 02/19/2013 | US8377897 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377450 Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2485120C Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/19/2013 | CA2388003C Expression of recombinant mature lysostaphin |
| 02/19/2013 | CA2375320C Dna vaccines for pets or for animals used in sports |
| 02/14/2013 | WO2013022991A2 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/14/2013 | WO2013022946A1 Methods of treating dna damage |
| 02/14/2013 | WO2013022829A2 Endomucin as an anti-inflammatory agent |
| 02/14/2013 | WO2013022092A1 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |
| 02/14/2013 | WO2013021784A1 Immune tolerance inducer |
| 02/14/2013 | WO2013020986A1 Polyanion nanocomplexes for therapeutic applications |
| 02/14/2013 | WO2012166588A3 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130040879 Methods For Treating Congestive Heart Failure |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039895 Mir-150 for the treatment of blood disorders |
| 02/14/2013 | US20130039890 Treatment of tumors with genetically engineered herpes virus |
| 02/14/2013 | US20130039888 Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | DE102011109868A1 Multiple Emulsion Multiple emulsion |
| 02/14/2013 | CA2844660A1 Methods of treating dna damage |
| 02/14/2013 | CA2844283A1 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/13/2013 | EP2557164A1 Induced activation in dendritic cells |
| 02/13/2013 | EP2557159A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma |
| 02/13/2013 | EP2556160A2 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21 |
| 02/13/2013 | EP2556149A1 Cell poration |
| 02/13/2013 | CN102933711A Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT) |
| 02/13/2013 | CN102933233A Agent for treating renal fibrosis |
| 02/13/2013 | CN102925449A Signal conductive protein in branchiostoma belcheri tsingtauense and expressed genes and application thereof |
| 02/13/2013 | CN102925443A Targeting silencing MyoX sequence preparation and vector construction of sequence |
| 02/13/2013 | CN102924604A Recombined vessel endothelium growth factor receptor, encoding genes thereof and application |
| 02/13/2013 | CN102921021A MiRNA-361 (micro-ribonucleic acid-361) and application of antisense nucleotide thereof |
| 02/13/2013 | CN102921020A Gene drug for combined treatment on tumors, and use thereof |
| 02/13/2013 | CN102921019A Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |